Cargando…
Immunosuppressants/lopinavir/ritonavir interaction: Relapse or persisting shedding of COVID-2019 , increased level of tacrolimus and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791907/ http://dx.doi.org/10.1007/s40278-021-88951-8 |
Ejemplares similares
-
Hydroxychloroquine/lopinavir/ritonavir/tacrolimus interaction: Increased tacrolimus level secondary to pharmacokinetic drug interaction and off label use: case report
Publicado: (2021) -
Immunosuppressants/lopinavir/ritonavir interaction: Various toxicities: case report
Publicado: (2020) -
Lopinavir/ritonavir/sirolimus interaction: Hepatitis following an off-label use: case report
Publicado: (2022) -
Lopinavir/ritonavir: Hyperlipidaemia following off-label use: case report
Publicado: (2020) -
Lopinavir/ritonavir: Bradyarrhythmia following an off-label use : case report
Publicado: (2020)